Pfizer (PFE) Stock Forecast & Price Target
PFE Analyst Ratings
Moderate Buy
8Buy14Hold1Sell
Based on 23 analysts giving stock ratings to Pfizer in the past 3 months
PFE Stock 12 Month Forecast
Average Price Target
EUR 26.48▼(-2.53% Downside)Based on 23 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is EUR 26.48 with a high forecast of EUR 32.19 and a low forecast of EUR 22.35. The average price target represents a -2.53% change from the last price of EUR 27.17.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 32.19
AverageEUR 26.48
LowEUR 22.35
Highest Price TargetHighestEUR 32.19Average Price TargetEUR 26.48Lowest Price TargetLowestEUR 22.35
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Emily Field | Barclays | EUR 22.35 | sell | -17.73%Downside | Reiterated | 11/03/26 | ||
| Chris Schott | J.P. Morgan | EUR 26.82 | hold | -1.28%Downside | Reiterated | 11/03/26 | ||
| Geoff Meacham | Citi | EUR 24.14 | hold | -11.15%Downside | Reiterated | 10/27/26 | ||
| Trung Huynh | RBC Capital | EUR 22.35 | hold | -17.73%Downside | Reiterated | 10/27/26 | ||
| Vamil Divan | Guggenheim | EUR 27.72 | buy | 2.01%Upside | Reiterated | 10/27/26 | ||
| Akash Tewari | Jefferies | EUR 32.19 | buy | 18.47%Upside | Reiterated | 10/26/26 | ||
| Louise Chen | Scotiabank | EUR 29.51 | buy | 8.60%Upside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | EUR 25.93 | hold | -4.57%Downside | Reiterated | 10/25/26 | ||
| Kerry Holford | Berenberg Bank | EUR 22.35 | hold | -17.73%Downside | Reiterated | 10/20/26 | ||
| Derek Archila | Wells Fargo | EUR 25.04 | hold | -7.86%Downside | Reiterated | 10/16/26 | ||
| Evan Seigerman | BMO Capital | EUR 31.29 | buy | 15.18%Upside | Reiterated | 10/12/26 | ||
| Jason Gerberry | Bank of America Securities | EUR 24.14→EUR 25.93 | hold | -4.57%Downside | Reiterated | 10/09/26 | ||
| Michael Yee | UBS | EUR 24.14 | hold | -11.15%Downside | Reiterated | 10/09/26 | ||
| Carter Gould | Cantor Fitzgerald | EUR 24.14→EUR 25.04 | hold | -7.86%Downside | Assigned | 10/08/26 | ||
| Nico Chen | DBS | EUR 31.29 | buy | 15.18%Upside | Reiterated | 10/08/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Emily Field | 11/03/26 | EUR 22.35 | sell | -17.73%Downside | Reiterated | Barclays | ||
| Chris Schott | 11/03/26 | EUR 26.82 | hold | -1.28%Downside | Reiterated | J.P. Morgan | ||
| Geoff Meacham | 10/27/26 | EUR 24.14 | hold | -11.15%Downside | Reiterated | Citi | ||
| Trung Huynh | 10/27/26 | EUR 22.35 | hold | -17.73%Downside | Reiterated | RBC Capital | ||
| Vamil Divan | 10/27/26 | EUR 27.72 | buy | 2.01%Upside | Reiterated | Guggenheim | ||
| Akash Tewari | 10/26/26 | EUR 32.19 | buy | 18.47%Upside | Reiterated | Jefferies | ||
| Louise Chen | 10/26/26 | EUR 29.51 | buy | 8.60%Upside | Reiterated | Scotiabank | ||
| Courtney Breen | 10/25/26 | EUR 25.93 | hold | -4.57%Downside | Reiterated | Bernstein | ||
| Kerry Holford | 10/20/26 | EUR 22.35 | hold | -17.73%Downside | Reiterated | Berenberg Bank | ||
| Derek Archila | 10/16/26 | EUR 25.04 | hold | -7.86%Downside | Reiterated | Wells Fargo | ||
| Evan Seigerman | 10/12/26 | EUR 31.29 | buy | 15.18%Upside | Reiterated | BMO Capital | ||
| Jason Gerberry | 10/09/26 | EUR 24.14→EUR 25.93 | hold | -4.57%Downside | Reiterated | Bank of America Securities | ||
| Michael Yee | 10/09/26 | EUR 24.14 | hold | -11.15%Downside | Reiterated | UBS | ||
| Carter Gould | 10/08/26 | EUR 24.14→EUR 25.04 | hold | -7.86%Downside | Assigned | Cantor Fitzgerald | ||
| Nico Chen | 10/08/26 | EUR 31.29 | buy | 15.18%Upside | Reiterated | DBS |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Pfizer
3 Months
Success Rate25/34 ratings generated profit
74%
Average Return
+4.22%
Copying Vamil Divan's trades and holding each position for 3 Months would result in 73.53% of your transactions generating a profit, with an average return of +4.22% per trade.
1 Year
Success Rate30/34 ratings generated profit
88%
Average Return
+12.37%
Copying Vamil Divan's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +12.37% per trade.
2 Years
Success Rate31/34 ratings generated profit
91%
Average Return
+18.46%
Copying Vamil Divan's trades and holding each position for 2 Years would result in 91.18% of your transactions generating a profit, with an average return of +18.46% per trade.
PFE Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 20 | 20 | 14 | 19 | 10 |
| Hold | 40 | 37 | 25 | 35 | 25 |
| Sell | 5 | 3 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 65 | 60 | 40 | 55 | 36 |
In the current month, PFE has received 10 Buy Ratings, 25 Hold Ratings, and 1 Sell Ratings. PFE average Analyst price target in the past 3 months is 26.48.
PFE Financial Forecast
HighEUR 0.74
ConsensusEUR 0.63
LowEUR 0.56
PFE Earnings Forecast
Next quarter’s earnings estimate for PFE is EUR 0.63 with a range of EUR 0.56 to EUR 0.74. The previous quarter’s EPS was EUR 0.78. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 15.9B
ConsensusEUR 15.1B
LowEUR 14.7B
PFE Sales Forecast
Next quarter’s sales forecast for PFE is EUR 15.10B with a range of EUR 14.66B to EUR 15.92B. The previous quarter’s sales results were EUR 14.83B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
PFE Stock Forecast FAQ
What is DE:PFE’s average 12-month price target, according to analysts?
Based on analyst ratings, Pfizer’s 12-month average price target is €26.48.
What is DE:PFE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:PFE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pfizer a Buy, Sell or Hold?
Pfizer has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 14 hold ratings and 1 sell ratings.
What is Pfizer’s share price target?
The average share price target for Pfizer is €26.48. This is based on 23 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €32.19, and the lowest forecast is €22.35. The average share price target represents a 2.53% decrease from the current price of €27.17.
What do analysts say about Pfizer?
Pfizer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Street analysts.
How can I buy shares of Pfizer?
To buy shares of DE:PFE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
